Atria Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.38M Sell
17,616
-1,775
-9% -$139K 0.02% 895
2025
Q1
$1.41M Buy
+19,391
New +$1.41M 0.02% 867
2023
Q4
Sell
-35,632
Closed -$2.47M 904
2023
Q3
$2.47M Sell
35,632
-1,788
-5% -$124K 0.04% 493
2023
Q2
$3.53M Buy
37,420
+1,179
+3% +$111K 0.06% 366
2023
Q1
$3M Buy
36,241
+3,037
+9% +$251K 0.06% 402
2022
Q4
$2.48M Sell
33,204
-3,765
-10% -$281K 0.05% 434
2022
Q3
$3.06M Sell
36,969
-885
-2% -$73.1K 0.07% 346
2022
Q2
$3.6M Sell
37,854
-7,763
-17% -$738K 0.08% 326
2022
Q1
$5.37M Buy
45,617
+4,925
+12% +$580K 0.09% 259
2021
Q4
$5.27M Sell
40,692
-838
-2% -$109K 0.09% 264
2021
Q3
$4.7M Buy
41,530
+3,717
+10% +$421K 0.08% 265
2021
Q2
$3.92M Buy
37,813
+2,725
+8% +$282K 0.08% 297
2021
Q1
$2.94M Buy
35,088
+2,053
+6% +$172K 0.07% 347
2020
Q4
$3.01M Buy
33,035
+2,168
+7% +$198K 0.07% 302
2020
Q3
$2.46M Buy
30,867
+10,152
+49% +$810K 0.07% 285
2020
Q2
$1.43M Buy
+20,715
New +$1.43M 0.05% 395
2020
Q1
Sell
-13,413
Closed -$1.04M 730
2019
Q4
$1.04M Buy
13,413
+2,760
+26% +$215K 0.03% 510
2019
Q3
$781K Buy
10,653
+366
+4% +$26.8K 0.03% 485
2019
Q2
$743K Sell
10,287
-525
-5% -$37.9K 0.03% 481
2019
Q1
$690K Sell
10,812
-1,779
-14% -$114K 0.03% 446
2018
Q4
$643K Buy
12,591
+1,275
+11% +$65.1K 0.03% 418
2018
Q3
$657K Buy
11,316
+69
+0.6% +$4.01K 0.03% 518
2018
Q2
$546K Sell
11,247
-1,614
-13% -$78.4K 0.02% 540
2018
Q1
$598K Buy
12,861
+2,040
+19% +$94.9K 0.03% 469
2017
Q4
$407K Sell
10,821
-1,596
-13% -$60K 0.02% 539
2017
Q3
$452K Buy
12,417
+849
+7% +$30.9K 0.02% 478
2017
Q2
$456K Buy
11,568
+339
+3% +$13.4K 0.03% 451
2017
Q1
$352K Buy
+11,229
New +$352K 0.02% 471
2016
Q4
Sell
-5,553
Closed -$223K 644
2016
Q3
$223K Buy
+5,553
New +$223K 0.02% 480
2015
Q1
Sell
-11,814
Closed -$251K 413
2014
Q4
$251K Sell
11,814
-1,512
-11% -$32.1K 0.03% 364
2014
Q3
$227K Buy
+13,326
New +$227K 0.02% 420